Both in R&D — Physical & Biological Sciences
IB Acquisition vs OmniAb
Over the past year IBAC returned +3.7% and OABI returned +268.8%; their daily moves had a correlation of -0.04.
IBAC +3.7% OABI +268.8%Growth of $1, one year, split-adjusted
| Metric | IBAC | OABI |
|---|---|---|
| Price | $10.81 | $4.86 |
| Market cap | $54.1M | $708.9M |
| Today | −0.46% | −6.18% |
| 1 month | −0.6% | +6.6% |
| 6 months | −0.2% | +230.6% |
| Year to date | +3.0% | +162.7% |
| 1 year | — | +228.4% |
| Revenue growth (YoY) | — | +78.3% |
| Gross margin | — | 92.3% |
| Net margin | — | −393.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 17.6× |
| Net cash | — | $64.2M |
| Dividend yield | — | — |
| Volatility (60d) | 20.1% | 73.0% |
| Short % of float | 0.3% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).